Penumbra Long-Term Debt 2011-2026 | PEN

Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.

Main characteristics:

Term exceeds 12 months
Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
Repaid through regular payments (interest and/or principal) over several years

Why long-term debt is needed:

Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital.
Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks.
Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.

A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.

If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.

It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.

Examples of long-term debt:

Mortgage loans for property purchases
Corporate bonds issued by a company to raise capital
Project financing — long-term loans for building or expanding production facilities
Leasing obligations for equipment or transport

Annual Long-Term Debt Penumbra

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
20.7 M	21.7 M	23.7 M	24.9 M	26.5 M	44.2 M	-	-	-	-	-	-	6 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
44.2 M	6 M	24 M

Quarterly Long-Term Debt Penumbra

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
21.2 M	21.8 M	21.2 M	22.2 M	22.5 M	23.1 M	23.8 M	23.9 M	24.4 M	24.9 M	25.3 M	-	26.1 M	26.5 M	26.8 M	51.9 M	27 M	27.1 M	27.1 M	27.1 M	27.1 M	26.7 M	26.7 M	26.7 M	26.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
51.9 M	21.2 M	26.2 M

Long-Term Debt of other stocks in the Medical devices industry

Issuer	Long-Term Debt	Price	% 24h	Market Cap	Country
Align Technology ALGN	88.2 M	$ 184.69	2.23 %	$ 13.8 B	USA
GenMark Diagnostics, Inc. GNMK	71.3 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	32.7 M	-	-26.83 %	$ 2.62 M	USA
Avinger AVGR	1.1 M	-	-20.74 %	$ 369 K	USA
AxoGen AXGN	48.4 M	$ 34.46	2.96 %	$ 1.59 B	USA
Axonics Modulation Technologies AXNX	7.56 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	3.59 M	-	1.37 %	$ 20.5 M	USA
AdaptHealth Corp. AHCO	1.72 B	$ 12.77	3.65 %	$ 1.73 B	USA
Allied Healthcare Products AHPI	2.93 K	-	3.58 %	$ 2.21 M	USA
BioSig Technologies BSGM	103 K	-	37.08 %	$ 85.7 M	USA
Obalon Therapeutics, Inc. OBLN	430 K	-	-5.86 %	$ 30.6 M	USA
Bio-Rad Laboratories BIO	1.2 B	$ 292.23	1.41 %	$ 8.24 B	USA
Conformis CFMS	20.6 M	-	-	$ 16.4 M	USA
EDAP TMS S.A. EDAP	2.16 M	$ 3.37	1.35 %	$ 126 M	France
Bruker Corporation BRKR	2.06 B	$ 39.9	2.18 %	$ 5.94 K	USA
Boston Scientific Corporation BSX	11.1 B	$ 63.82	1.01 %	$ 94.5 B	USA
Cytosorbents Corporation CTSO	16.7 M	$ 0.59	0.67 %	$ 36.7 M	USA
Apollo Endosurgery APEN	34 M	-	-	$ 475 M	USA
Cardiovascular Systems CSII	1.33 M	-	0.15 %	$ 844 M	USA
ClearPoint Neuro CLPT	49.1 M	$ 10.38	3.7 %	$ 294 M	USA
Dynatronics Corporation DYNT	1.11 M	-	14.99 %	$ 929 K	USA
Second Sight Medical Products EYES	17.1 M	-	-0.97 %	$ 54.4 M	USA
Electromed ELMD	1.1 M	$ 25.21	1.47 %	$ 213 M	USA
CryoLife, Inc. CRY	290 M	-	-4.14 %	$ 702 M	USA
GBS GBS	1.65 M	-	-0.57 %	$ 7.12 M	USA
Itamar Medical Ltd. ITMR	154 K	-	0.03 %	$ 1.58 B	Israel
Helius Medical Technologies HSDT	12 K	$ 1.98	-2.46 %	$ 1.2 M	USA
Misonix, Inc. MSON	38.6 M	-	-	$ 462 M	USA
Inogen INGN	14.3 M	$ 6.34	-1.71 %	$ 169 M	USA
Neovasc NVCN	7.64 M	-	-	$ 111 M	Canada
IRIDEX Corporation IRIX	98 K	$ 1.03	-	$ 17.4 M	USA
Globus Medical GMED	436 K	$ 94.94	2.11 %	$ 12.8 B	USA
OrthoPediatrics Corp. KIDS	99.8 M	$ 17.86	5.37 %	$ 419 M	USA
Butterfly Network BFLY	20.4 M	$ 4.44	3.74 %	$ 940 M	USA
Intersect ENT, Inc. XENT	63.6 M	-	-	$ 955 M	USA
BIOLASE BIOL	11.8 M	-	-13.19 %	$ 166 K	USA
LENSAR LNSR	1.99 M	$ 6.04	2.03 %	$ 72.2 M	USA
Delcath Systems DCTH	835 K	$ 10.88	4.11 %	$ 390 M	USA
Inspire Medical Systems INSP	30 M	$ 56.83	3.48 %	$ 1.67 B	USA
CONMED Corporation CNMD	834 M	$ 39.73	3.3 %	$ 1.23 B	USA
LivaNova PLC LIVN	345 M	$ 64.99	0.63 %	$ 3.55 B	Britain
Integer Holdings Corporation ITGR	1.19 B	$ 88.63	1.03 %	$ 3.08 B	USA
FONAR Corporation FONR	155 K	$ 18.76	0.27 %	$ 123 M	USA
Invacare Corporation IVC	354 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	598 M	$ 78.2	0.1 %	$ 45.7 B	USA
Myomo MYO	11.2 M	$ 0.79	8.49 %	$ 33.1 M	USA